About the role
This role provides analytical, coordination, and execution support to the Head of Finance – EuCan Cluster.
The role will support the Head of Finance EuCan Cluster in managing Finance business partnering for CSL Commercial Operations across Canada, the UK/Ireland, France, Italy, Spain and Portugal.
This role involves developing analysis, creating presentations for the Head of Finance EuCan cluster to ensure alignment with both regional and global objectives. The Regional Finance Business Partner EuCan plays a key role in enabling financial processes and delivering accurate and timely financial planning, reporting, and analysis in collaboration with the FP&A team.
FBP & Decision Support
- Support the Head of Finance in preparing financial insights, materials and recommendations for EuCan business and leadership discussions.
- Develop analyses to support business decision‑making (performance trends, risks, opportunities).
- Prepare structured briefing packs, management presentations, and executive summaries.
Planning, Forecasting & Reporting
- Support annual budget, forecast, and outlook cycles across EuCan markets.
- Perform variance analysis (actuals vs budget / forecast), identifying key drivers and issues.
- Consolidate inputs from markets and ensure completeness, accuracy, and consistency.
- Performance & KPI Analysis
- Track and analyze key financial and commercial KPIs across EuCan.
- Support preparation of dashboards and management reports.
- Assist in identifying emerging risks and opportunities across markets.
Process & Data Management
- Maintain high data quality across financial models, reports, and templates.
- Support continuous improvement of reporting, automation, and standardisation.
- Coordinate timelines, submissions, and follow‑ups across markets and FP&A teams.
Stakeholder Coordination
- Act as a coordination point with country FBPs, FP&A, and finance operations teams. Support clear communication and follow‑up on agreed actions.
- Build effective working relationships across Finance and Commercial teamsSupport the evolution of the Finance Business Partnering model across markets, influencing scope clarity and elevating insights and storytelling in line with the leadership direction
Qualificatrions and Experience
- Bachelor’s degree in Finance, Accounting, or other Business related discipline
- CPA/CA or MBA a plus
- 5+ years of experience in various finance roles including, business partnering, financial planning, reporting, accounting operations or related fields, including experience in the biopharmaceutical or manufacturing sector
- Experience with using dashboarding and visualization software (e.g. PowerBi) is preferable
- Experience supporting commercial functions including, but not limited to pharmaceutical industry is desirable.
- Fluency in one or more of the following languages (in addition to English) highly desirable: French, Italian, Spanish, Portuguese
About CSL Behring
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
Our Benefits
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
You Belong at CSL
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging
Equal Opportunity Employer
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.
Aplyr's read
CSL is a leader in biotechnology, focusing on therapies for rare diseases, with a diverse team dedicated to innovation and global impact.
What's promising
- •CSL has a strong focus on rare and serious diseases, offering a unique niche in the biotech industry.
- •Recent hiring for senior roles indicates growth and investment in leadership and strategic capabilities.
- •Global presence provides employees with opportunities for international collaboration and career development.
What to watch
- •Highly specialized focus may limit opportunities for those outside the biotechnology field.
- •Complex regulatory environment can pose challenges for compliance and operational efficiency.
- •Rapid expansion may lead to integration challenges across diverse global teams.
Why CSL
- •CSL's commitment to rare disease therapies differentiates it from broader-focused biotech firms.
- •The company offers a wide array of roles, from regulatory affairs to ethics and compliance.
- •CSL's global operations provide a platform for employees to engage in diverse cultural and professional experiences.
Aplyr’s read is generated by AI from public sources. Was it useful?
About CSL
CSL is a global biotechnology company that develops and delivers innovative therapies for people with serious and rare diseases.